Related Experiment Video
Updated: Dec 11, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Quantifying risk factors for ischemic colitis: A nationwide, retrospective cohort study
Patrick A Twohig1, Aakash Desai2, Jacob Skeans3
1Department of Internal Medicine, MetroHealth Medical Center, Case Western Reserve University, 2500 MetroHealth Drive, Cleveland, OH, 44109, USA. patwohig@gmail.com.
This study quantifies risks for ischemic colitis (IC), finding hyperlipidemia, hypertension, and heart failure significantly increase odds. Beta blockers and inflammatory diseases also elevate IC risk, aiding early patient identification.
Area of Science:
- Gastroenterology
- Epidemiology
- Clinical Medicine
Background:
- Numerous factors are linked to ischemic colitis (IC), but their relative risks are not well-defined.
- Understanding these associations is crucial for managing this condition.
Purpose of the Study:
- To quantify the risk of specific diseases and medications associated with ischemic colitis (IC).
- To identify novel risk factors for ischemic colitis.
Main Methods:
- A population-based retrospective analysis using the IBM Explorys database (1999-2018) of 57 million de-identified US patients.
- Calculation of odds ratios (OR) for IC in relation to various diseases and medications.
- Stratification of IC patients by age to analyze trends across different age groups.
Main Results:
- Hyperlipidemia showed the highest association with IC (OR 15.3), supporting atherosclerosis as a major risk factor.
- Hypertension, congestive heart failure, constipation, prior abdominal surgery, and atrial fibrillation all had OR > 10.
- Novel findings include increased IC risk associated with beta blockers (OR 9.6) and pro-inflammatory conditions like vasculitis, rheumatoid arthritis, and malignancy.
Conclusions:
- Early identification of ischemic colitis is essential to reduce patient morbidity and mortality.
- Integrating epidemiologic data into clinical algorithms can improve the rapid identification of at-risk patients.
More Related Videos
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...

